v3.26.1
Condensed Statement of Operations - USD ($)
 3 Months Ended 4 Months Ended 6 Months Ended 12 Months Ended
Feb. 25, 2026
Jun. 30, 2026
Jun. 30, 2026
Dec. 31, 2024
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Operating Expenses [Abstract]              
General, formation and administrative expenses $ 33,697 $ 184,418 $ 249,667        
Loss from operations   (184,418) (249,667)        
Other income:              
Interest earned on marketable securities held in Trust Account   238,468 238,468        
Total other income   238,468 238,468        
Other income / (expense):              
Net income (loss) $ (33,697) 54,050 (11,199)        
Net income (loss) per ordinary share, basic $ (0.18)            
Net income (loss) per ordinary share, diluted $ (0.18)            
Weighted average ordinary shares outstanding, basic 189,076            
Weighted average ordinary shares outstanding, diluted 189,076            
Class A ordinary shares [Member]              
Other income / (expense):              
Net income (loss)   $ 37,841 $ (7,093)        
Net income (loss) per ordinary share, basic   $ 0.01 $ 0        
Net income (loss) per ordinary share, diluted   $ 0.01 $ 0        
Weighted average ordinary shares outstanding, basic   3,379,121 2,329,545        
Weighted average ordinary shares outstanding, diluted   3,379,121 2,329,545        
Class A and B ordinary shares [Member]              
Other income / (expense):              
Net income (loss)   $ 16,209 $ (4,106)        
Net income (loss) per ordinary share, basic   $ 0.01 $ 0        
Net income (loss) per ordinary share, diluted   $ 0.01 $ 0        
Weighted average ordinary shares outstanding, basic   1,447,430 1,348,785        
Weighted average ordinary shares outstanding, diluted   1,447,430 1,348,785        
OHB Pediatrics Ltd [Member]              
Operating Expenses [Abstract]              
General, formation and administrative expenses       $ 15,000 $ 2,813,000 $ 710,000 $ 1,297,000
Research and development       342,000 10,695,000 2,210,000 14,302,000
Total operating expenses       357,000 13,508,000 2,920,000 15,599,000
Loss from operations       (357,000) (13,508,000) (2,920,000) (15,599,000)
Other income / (expense):              
Foreign currency gain (loss)       0 1,000 (38,000) (51,000)
Total other income / (expense)       0 1,000 (38,000) (51,000)
Loss from operations before taxes       (357,000) (13,507,000) (2,958,000) (15,650,000)
Income tax expense       0 0 0 0
Net income (loss)       $ (357,000) $ (13,507,000) $ (2,958,000) $ (15,650,000)
Net income (loss) per ordinary share, basic       $ (0.01) $ (0.22) $ (0.05) $ (0.25)
Net income (loss) per ordinary share, diluted       $ (0.01) $ (0.22) $ (0.05) $ (0.25)
Weighted average ordinary shares outstanding, basic       62,312,500 62,312,500,000 62,312,500,000 62,312,500
Weighted average ordinary shares outstanding, diluted       62,312,500 62,312,500,000 62,312,500,000 62,312,500